The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status
Trigg, Ricky M., Lee, Liam C., Prokoph, Nina, Jahangiri, Leila, Reynolds, C. Patrick, Amos Burke, G. A., Probst, Nicola A., Han, Miaojun, Matthews, Jamie D., Kai Lim, Hong, Manners, Eleanor, Martinez,Volume:
10
Journal:
Nature Communications
DOI:
10.1038/s41467-019-13315-x
Date:
December, 2019
File:
PDF, 1.78 MB
2019